Advanced Adenocarcinoma Clinical Trial
Official title:
An Open-label, Multicenter, Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Efficacy of BA3182, a Bispecific Epithelial Cell Adhesion Molecule (EpCAM)/CD3 Antibody, in Patients With Advanced Adenocarcinoma
The objective of this study is to assess safety and efficacy of BA3182 in Advanced Adenocarcinoma
This is a multi-center, open-label, Phase 1 study designed to evaluate the safety, tolerability, PK, immunogenicity, and antitumor activity of BA3182 in patients with advanced adenocarcinoma. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05101356 -
A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma
|
Phase 1/Phase 2 | |
| Completed |
NCT05374369 -
Retrospective Analysis of Colorectal Cancer Screening Results
|
||
| Completed |
NCT04722055 -
A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in China
|
||
| Recruiting |
NCT06059963 -
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
|
||
| Completed |
NCT01506973 -
A Phase I/II/Pharmacodynamic Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane to Inhibit Autophagy in Pancreatic Cancer
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT04739722 -
Colorectal Cancer and Pre-Cancerous Adenoma Non-Invasive Detection Test Study
|
N/A |